|
BCL11A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.97979999458664E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03490000014084E-07 |
| Normal-vs-Stage2 |
8.66549999534172E-08 |
| Normal-vs-Stage3 |
1.69810000505421E-08 |
| Normal-vs-Stage4 |
5.56220000058616E-08 |
| Stage1-vs-Stage2 |
6.547600E-01 |
| Stage1-vs-Stage3 |
1.041230E-01 |
| Stage1-vs-Stage4 |
4.102400E-01 |
| Stage2-vs-Stage3 |
4.632400E-01 |
| Stage2-vs-Stage4 |
7.591400E-01 |
| Stage3-vs-Stage4 |
7.136600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41569999454217E-08 |
| Normal-vs-AfricanAmerican |
2.06169999961148E-07 |
| Normal-vs-Asian |
6.75619999945809E-07 |
| Caucasian-vs-AfricanAmerican |
9.798400E-01 |
| Caucasian-vs-Asian |
2.409600E-01 |
| AfricanAmerican-vs-Asian |
4.312400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6664000002109E-07 |
| Normal-vs-Female |
3.48869999555745E-08 |
| Male-vs-Female |
2.105400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.73420000160985E-08 |
| Normal-vs-Age(41-60Yrs) |
2.0908999975866E-08 |
| Normal-vs-Age(61-80Yrs) |
1.24659999989341E-07 |
| Normal-vs-Age(81-100Yrs) |
7.617300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.913620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.901400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.977600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.307800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.743630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.400200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.146200E-01 |
| Classical-VS-Follicular |
7.622600E-01 |
| Classical-VS-Other |
7.694400E-01 |
| Classical-VS-Normal |
1.03400000006637E-07 |
| Tall-VS-Follicular |
4.162400E-01 |
| Tall-VS-Other |
7.798600E-01 |
| Tall-VS-Normal |
1.20379999968279E-07 |
| Follicular-VS-Other |
8.398200E-01 |
| Follicular-VS-Normal |
9.29400000293512E-08 |
| Other-VS-Normal |
1.50297000000021E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.54190000451516E-08 |
| Normal-vs-N1 |
8.60930005064375E-09 |
| N0-vs-N1 |
6.491900E-02 |
|
|
